Fibrosis and inflammatory cells in human chronic chagasic myocarditis: Scanning electron microscopy and immunohistochemical observations

International Journal of Cardiology

Volumn 66, Issue 2, 1998, Pages 183-194

  Rossi, Marcos A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Chagas' disease; Chagasic myocarditis; Connective tissue matrix; Immunohistochemistry; Myocardial fibrosis; Scanning electron microscopy; Trypanosoma cruzi

Indexed keywords

COLLAGEN FIBRIL;

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART MUSCLE FIBROSIS; HEART VENTRICLE ARRHYTHMIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MACROPHAGE; MALE; MYOCARDITIS; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SUDDEN DEATH; T LYMPHOCYTE;

EID: 0032582240     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(98)00208-3     Document Type: Article

References (45)

1. [1] Maciel BC, Almeida-Filho OC, Schmidt A, Marin-Neto JA. Ventricular function in Chagas' heart disease. São Paulo Med J 1995;113:814-20.
2. [2] Köberle F. Chagas' disease and Chagas' syndromes: the pathology of American trypanosomiasis. Adv Parasitol 1968;6:63-116.
3. [3] Bestetti RB, Dalbo CMR, Arruda CA, Correia-Filho D, Freitas OC. Predictors of sudden cardiac death for patients with Chagas' disease: a hospital derived cohort study. Cardiology 1996;87:481-7.
4. [4] Rossi MA. The pattern of myocardial fibrosis in chronic Chagas' heart disease. Int J Cardiol 1991;30:335-40.
5. [5] Rossi MA, Bestetti RB. The challenge of Chagas' cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes, and therapeutic implications. Cardiology 1995;86:1-7.
6. [6] Borg TK, Ranson WF, Moshlehy FA, Caulfield JB. Structural basis of ventricular stiffness. Lab Invest 1981;44:49-54.
7. [7] Robinson TF, Factor SM, Sonnenblick EH. The heart as a suction pump. Sci Am 1986;254:84-91.
8. [8] Factor SM, Robinson TF. Comparative connective tissue structure-function relationships in biologic pumps. Lab Invest 1988;58:150-6.
9. [9] Weber KT, Sun Y, Tyagi SC, Cleutjens JPM. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 1994;26:279-92.
10. [10] Assayag P, Carré F, Chevalier B, Mansier P, Swynghedauw B. Compensated cardiac hypertrophy: arrhythmogenicity and the new myocardial phenotype. I. Fibrosis. Cardiovasc Res 1997;34:439-44.
11. [11] Hinglais N, Heudes D, Nicoletti A, et al. Colocalization of myocardial fibrosis and inflammatory cells in rats. Lab Invest 1994;70:286-94.
12. [12] Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariéty J, Michel J-P. Inflammatory cells and myocardial fibrosis: spatial and temporal distribution in renovascular hypertensive rats. Cardiovasc Res 1996;32:1096-107.
13. [13] Dolber PC, Spach MS. Picrosirius red staining of cardiac muscle following phosphomolybdic treatment. Stain Technol 1987;62:23-6.
14. [14] Ohtani O. Three-dimensional organization of the connective tissue fibers of the human pancreas: a scanning electron microscopic study of NaOH treated tissue. Arch Histol Jpn 1987;50:557-66.
15. [15] Rossi MA, Abreu MA, Santoro LB. Connective tissue skeleton of the human heart: demonstration by cell-maceration scanning electron microscope method. Circulation 1998;97:934-5.
16. [16] Yoshikane H, Honda M, Goto Y, Morioka S, Ooshima A, Moriyama K. Collagen in dilated cardiomyopathy. Scanning electron microscopic and immunohistochemical observations. Jpn Circ J 1992;56:899-910.
17. [17] Rossi MA. Pathologic fibrosis and connective tissue matrix in left ventricular hypertrophy due to chronic arterial hypertension in humans. J Hypertens 1998;16:1031-41.
18. [18] Robinson TF, Cohen-Gould L, Factor SM. The skeletal framework of mammalian heart muscle: arrangement of inter- and pericellular connective tissue structures. Lab Invest 1983;49:482-98.
19. [19] Robinson TF, Factor SM, Capasso JM, Wittenberg IA, Blumenfeld OO, Seiffer S. Morphology, composition, and functions of struts between cardiac myocytes of rat and hamster. Cell Tissue Res 1987;249:247-55.
20. [20] Borg TK, Caulfield JB. The collagen matrix of the heart. Fed Proc 1981;40:2037-41.
21. [21] Spach MS, Dolber PC. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopical level in human cardiac muscle. Evidence for electrical uncoupling side-to-side fiber connections with increasing age. Circ Res 1986;58:356-71.
22. [22] Rossi MA. Patterns of myocardial fibrosis in idiopathic cardiomyopathies and chronic Chagasic cardiopathy. Can J Cardiol 1991;7:287-94.
23. [23] Rossi MA, Ramos SG. Pathogenesis of chronic Chagas'myocarditis: an overview. Cardiovasc Path 1996;5:197-202.
24. [24] Ribeiro-dos-Santos R, Rossi MA. Imunopatologia: In: Cançado JR, Chuster M, editors. Cardiopatia chagásica. Belo Horizonte: Fundação Carlos Chagas, 1985:10-22.
25. [25] Ribeiro-dos-Santos R, Rossi MA, Laus JL, Silva JS, Savino W, Mengel J. Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 1992;175:29-39.
26. [26] Mengel J, Rossi MA. Chronic myocarditis pathogenesis: dependence on autoimmune and micro vascular factors. Am Heart J 1992;124:1052-7.
27. [27] Kalil J, Cunha-Neto E. Autoimmunity in Chagas' disease cardiomyopathy: fulfilling the criteria at last? Parasitol Today 1996;12:396-9.
28. [28] Oliveira JSM. A natural model of intrinsic heart system denervation: Chagas' cardiopathy. Am Heart J 1985;110:1092-8.
29. [29] Ramos SG, Matturri L, Rossi L, Rossi MA. Cardiac extrinsic neuropathy: lesions of mediastinal paraganglia in chronic chagasic cardiomyopathy. Cardiovasc Path 1996;5:227-31.
30. [30] Ben Younès-Chennoufi A, Hontebeyrie-Joskowicz M, Tricottet V, Eisen H, Reynes M, Said G. Persistence of Trypanosoma cruzi antigens in the inflammatory lesion of chronically infected mice. Trans Roy Soc Trop Med Hyg 1988;82:77-83.
31. [31] Higuchi ML, Brito T, Reis MM, et al. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc Path 1993;2:101-6.
32. [32] Rossi MA, Gonçalves S, Ribeiro-dos-Santos R. Experimental Trypanosoma cruzi myocarditis in BALB/c mice. The potential role of intravascular platelet aggregation in its genesis. Am J Pathol 1984;114:209-16.
33. [33] Rossi MA. Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. Am Heart J 1990;120:233-6.
34. [34] Morris SA, Tanowitz HB, Witner M, Bilezikian JP. Pathophysiological insights into the cardiomyopathy of Chagas' disease. Circulation 1990;82:1900-9.
35. [35] Tanowitz HB, Morris SA, Factor SM, Weiss LM, Wittner M. Parasitic diseases of the heart. I: Acute and chronic Chagas' disease. Cardiovasc Path 1992;1:7-15.
36. [36] Marin-Neto JA, Marzullo P, Marcassa C, et al. Myocardial perfusion abnormalities in chronic Chagas' disease as detected by thalium-201 scintigraphy. Am J Cardiol 1992;69:780-4.
37. [37] Torres FV, Acquatella H, Condado A, Dinsmore R, Palacios IF. Coronary vascular reactivity is abnormal in patients with Chagas' disease. Am Heart J 1995;129:945-1001.
38. [38] Rossi MA, Carobrez SG. Experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice: histochemical evidence of hypoxic changes in the myocardium. Br J Exp Path 1985;66:155-66.
39. [39] Piguet PF, Collart MA, Grau GE, Kapanci Y, Vassali P. Tumor necrosis factor/cachetin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 1989;170:655-63.
40. [40] Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991;12:17-23.
41. [41] Lange LG, Schreiner GF. Immune mechanisms of cardiac disease. New Engl J Med 1994;330:1129-35.
42. [42] Speir E, Yi-Fu Z, Lee M, Shrivastav S, Cassels W. Fibroblast growth factors are present in adult cardiac myocytes in vivo. Biochem Biophys Res Commun 1988;157:1336-40.
43. [43] Wei CM, Lerman A, Rodeheffer RJ, et al. Endothelin in human congestive failure. Circulation 1994;89:1580-6.
44. [44] Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita Y. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 1996;384:353-5.
45. [45] Kahaleh MB. Endothelin, an endothelial-dependent vasoconstrictor in scleroderma. Enhanced production and profibrotic action Arthritis Rheum 1991;34:978-83.